Universal Germline Testing in the Community

Status unconfirmed

Conditions studied: Cancer, Solid Tumor, Solid Tumor, Adult

In brief

This study seeks to enroll participants who have a diagnosis of a solid tumor cancer and are willing to undergo germline genetic testing for cancer risk. At baseline, patients will be asked to provide 2 types of blood samples: 1 tube for clinical genetic testing and 2 tubes for future research use. A tumor sample from a previous resection or biopsy will also be obtained and sent to the sponsor. The clinician will be asked to provide relevant medical history and demographic information to the sponsor in the form of electronic case report forms.

Key facts

Study ID

NCT05416710

Run by

Invitae Corporation

People needed

1000

Starts

2022-06-01

Expected to finish

2025-06-01

Last updated by the study team

2022-12-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient has consented to germline genetic testing
• Patient has a histologically confirmed diagnosis of a solid tumor cancer
• Patient is willing to release previously collected tissue sample
• Patient is willing to provide research blood samples
• Patient must be at least 18 years of age

You may not qualify if…

• Patient is unable to consent.
• Patient with hematologic malignancy

Where it is running

• Carolina Blood and Cancer Care Associates, PA' — Rock Hill, South Carolina, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.